Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.71M | 5.79M | 4.05M | 1.30M | 1.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.71M | 5.79M | 4.05M | 1.30M | 1.15M |
| Operating Income | -6.71M | -5.79M | -4.05M | -1.30M | -1.15M |
| Income Before Tax | -7.71M | -6.15M | -4.21M | -1.39M | -1.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.71 | -6.15 | -4.21 | -1.39 | -1.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.71M | -6.15M | -4.21M | -1.39M | -1.21M |
| EBIT | -6.71M | -5.79M | -4.05M | -1.30M | -1.15M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.36 | -0.33 | -0.26 | -0.09 | -0.08 |
| Normalized Basic EPS | -0.23 | -0.20 | -0.16 | -0.06 | -0.05 |
| EPS Diluted | -0.37 | -0.33 | -0.26 | -0.09 | -0.08 |
| Normalized Diluted EPS | -0.23 | -0.20 | -0.16 | -0.06 | -0.05 |
| Average Basic Shares Outstanding | 87.11M | 74.72M | 62.63M | 61.07M | 60.52M |
| Average Diluted Shares Outstanding | 87.11M | 74.72M | 62.63M | 61.07M | 60.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |